CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

NEOGEN CORP

NEOG
$2.99BMid Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for NEOG. That does not mean none is planned.

Get an email about NEOG's next catalysts

Track NEOGEN (NEOG) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

Market Overview

Stock performance and key metrics

NASDAQIn Vitro & In Vivo Diagnostic SubstancesGenomicsπŸ‡ΊπŸ‡ΈNorth AmericaLANSING2.1K employees

Neogen Corporation is an international food safety company that provides test kits and relevant products to detect dangerous substances in food. The company was founded in 1982 and is based in Lansing, Michigan. The company serves a wide range of countries including Canada, United States, the United Kingdom, parts of Europe, Mexico and Brazil, India, and China, among others. The company operates a product line of over 100 drug detection test kits worldwide for the detection of about 300 abused and therapeutic drugs in animal treatment. In 2009, it became a vendor of the Chinese government and has been engaged in researching China-specific food safety and plant health issues.

Website
Drug Pipeline

No drugs found in this phase.

Frequently asked questions

When is NEOGEN CORP's next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for NEOGEN CORP (NEOG) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track NEOG biotech catalysts?β†’

Add NEOG to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow NEOGEN CORP's live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply